Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,407 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response.
Storey CM, Altai M, Bicak M, Veach DR, Lückerath K, Adrian G, McDevitt MR, Kalidindi T, Park JE, Herrmann K, Abou D, Zedan W, Peekhaus N, Klein RJ, Damoiseaux R, Larson SM, Lilja H, Thorek D, Ulmert D. Storey CM, et al. Among authors: herrmann k. Mol Cancer Res. 2023 Apr 1;21(4):307-315. doi: 10.1158/1541-7786.MCR-22-0736. Mol Cancer Res. 2023. PMID: 36608299 Free PMC article.
Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma.
Ferdinandus J, Fendler WP, Lueckerath K, Berliner C, Kurzidem S, Hadaschik E, Klode J, Zimmer L, Livingstone E, Schadendorf D, Herrmann K, Becker JC, Ugurel S. Ferdinandus J, et al. Among authors: herrmann k. J Nucl Med. 2022 Mar;63(3):396-398. doi: 10.2967/jnumed.121.262344. Epub 2021 Sep 2. J Nucl Med. 2022. PMID: 34475234 Free article.
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities.
Fendler WP, Pabst KM, Kessler L, Fragoso Costa P, Ferdinandus J, Weber M, Lippert M, Lueckerath K, Umutlu L, Kostbade K, Mavroeidi IA, Schuler M, Ahrens M, Rischpler C, Bauer S, Herrmann K, Siveke JT, Hamacher R. Fendler WP, et al. Among authors: herrmann k. Clin Cancer Res. 2022 Oct 3;28(19):4346-4353. doi: 10.1158/1078-0432.CCR-22-1432. Clin Cancer Res. 2022. PMID: 35833949 Free PMC article.
Key Regulatory Elements of the TGFβ-LRRC15 Axis Predict Disease Progression and Immunotherapy Resistance Across Cancer Types.
Storey CM, Cheng M, Altai M, Park JE, Tran J, Lueong SS, Thorek D, Mao L, Zedan W, Yuen C, Ridley A, Trajovic-Arsic M, Herrmann K, Subuhdi SK, Siddiqui BA, Lückerath K, Siveke J, Damoiseaux R, Yang X, Ulmert D. Storey CM, et al. Among authors: herrmann k. bioRxiv [Preprint]. 2024 Nov 25:2024.11.22.624939. doi: 10.1101/2024.11.22.624939. bioRxiv. 2024. PMID: 39651139 Free PMC article. Preprint.
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0.
Fendler WP, Eiber M, Beheshti M, Bomanji J, Ceci F, Cho S, Giesel F, Haberkorn U, Hope TA, Kopka K, Krause BJ, Mottaghy FM, Schöder H, Sunderland J, Wan S, Wester HJ, Fanti S, Herrmann K. Fendler WP, et al. Among authors: herrmann k. Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1014-1024. doi: 10.1007/s00259-017-3670-z. Eur J Nucl Med Mol Imaging. 2017. PMID: 28283702
1,407 results